Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2018 | AMPK: a role in type 2 diabetes, cancer and Alzheimer’s disease?

During a talk at the Alzheimer’s Research UK (ARUK) Conference 2018, held in London, UK, Grahame Hardie, FRS, FRSE, FMedSci, of the University of Dundee, Dundee, UK, discussed the AMP-activated kinase (AMPK) pathway and its possible protective role in neurodegenerative diseases such as Alzheimer’s disease. Here, Prof. Hardie speaks about some of the other diseases in which AMPK is proposed to play a role, including type 2 diabetes and AMPK’s complex relationship with cancer.

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.